01176nas a2200457   4500000000100000008004100001260000900042653003900051653001200090653002900102653002300131653001900154653002000173653002600193653002700219653002700246653001600273653001100289653002300300653001200323653001700335653001600352653001400368653001900382653003900401653001100440653002100451653002100472653002700493653001900520653001900539100001600558700001600574700001500590700001200605700001400617245005400631300001100685490000800696022001400704       1988                            d  c198810aAcquired Immunodeficiency Syndrome10aAnimals10aAntigen-Antibody Complex10aBiological Factors10aChagas disease10aChronic Disease10aComplement Activation10aDemyelinating Diseases10aDisease Models, Animal10aGlycolipids10aHumans10aImmunity, Cellular10aleprosy10aLyme Disease10aLymphokines10aMonokines10aNervous System10aNeuritis, Autoimmune, Experimental10aOxygen10aParaproteinemias10aPolyneuropathies10aPolyradiculoneuropathy10aProstaglandins10aVirus Diseases1 aHartung H P1 aHeininger K1 aSchäfer B1 aFierz W1 aToyka K V00aImmune mechanisms in inflammatory polyneuropathy.  a122-610 v540  a0077-8923